Definitive Healthcare (DH) Competitors

$0.87 -0.02 (-2.06%)

As of 03:08 PM Eastern

DH vs. ECX, SPT, XNET, TBRG, and BIGC

Should you buy Definitive Healthcare stock or one of its competitors? MarketBeat compares Definitive Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Definitive Healthcare include ECARX (ECX), Sprout Social (SPT), Xunlei (XNET), TruBridge (TBRG), and Bigcommerce (BIGC). These companies are all part of the "computer software" industry.

How does Definitive Healthcare compare to ECARX?

Definitive Healthcare (NASDAQ:DH) and ECARX (NASDAQ:ECX) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

ECARX has a net margin of -7.75% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat ECARX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-76.04%	4.04%	1.99%
ECARX	-7.75%	N/A	-11.70%

In the previous week, Definitive Healthcare had 16 more articles in the media than ECARX. MarketBeat recorded 17 mentions for Definitive Healthcare and 1 mentions for ECARX. ECARX's average media sentiment score of 0.93 beat Definitive Healthcare's score of 0.43 indicating that ECARX is being referred to more favorably in the news media.

Company	Overall Sentiment
Definitive Healthcare	Neutral
ECARX	Positive

98.7% of Definitive Healthcare shares are held by institutional investors. 16.3% of Definitive Healthcare shares are held by insiders. Comparatively, 20.0% of ECARX shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Definitive Healthcare currently has a consensus target price of $2.77, suggesting a potential upside of 218.74%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Definitive Healthcare is more favorable than ECARX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00
ECARX	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Definitive Healthcare has a beta of 1.34, indicating that its share price is 34% more volatile than the broader market. Comparatively, ECARX has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market.

ECARX has higher revenue and earnings than Definitive Healthcare. ECARX is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.38	-$138.93M	-$1.62	N/A
ECARX	$847.90M	0.49	-$66.04M	-$0.20	N/A

Summary

Definitive Healthcare beats ECARX on 10 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Sprout Social?

Sprout Social (NASDAQ:SPT) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Sprout Social has a net margin of -8.18% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Sprout Social's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sprout Social	-8.18%	-13.90%	-5.72%
Definitive Healthcare	-76.04%	4.04%	1.99%

In the previous week, Sprout Social had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 18 mentions for Sprout Social and 17 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.43 beat Sprout Social's score of 0.34 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sprout Social	2 Very Positive mention(s)	0 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Definitive Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

98.7% of Definitive Healthcare shares are held by institutional investors. 9.6% of Sprout Social shares are held by company insiders. Comparatively, 16.3% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Sprout Social currently has a consensus price target of $13.22, suggesting a potential upside of 123.16%. Definitive Healthcare has a consensus price target of $2.77, suggesting a potential upside of 218.74%. Given Definitive Healthcare's higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than Sprout Social.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sprout Social	2 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

Sprout Social has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market.

Sprout Social has higher revenue and earnings than Definitive Healthcare. Sprout Social is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sprout Social	$457.55M	0.77	-$43.33M	-$0.66	N/A
Definitive Healthcare	$241.52M	0.38	-$138.93M	-$1.62	N/A

Summary

Definitive Healthcare beats Sprout Social on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Xunlei?

Xunlei (NASDAQ:XNET) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Xunlei has higher revenue and earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Xunlei, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xunlei	$460.43M	0.85	$1.05B	$16.43	0.38
Definitive Healthcare	$241.52M	0.38	-$138.93M	-$1.62	N/A

Xunlei has a net margin of 227.29% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Xunlei's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Xunlei	227.29%	1.41%	1.17%
Definitive Healthcare	-76.04%	4.04%	1.99%

In the previous week, Definitive Healthcare had 15 more articles in the media than Xunlei. MarketBeat recorded 17 mentions for Definitive Healthcare and 2 mentions for Xunlei. Xunlei's average media sentiment score of 1.33 beat Definitive Healthcare's score of 0.43 indicating that Xunlei is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Xunlei	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Xunlei has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market.

5.1% of Xunlei shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 21.7% of Xunlei shares are held by company insiders. Comparatively, 16.3% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Definitive Healthcare has a consensus price target of $2.77, suggesting a potential upside of 218.74%. Given Definitive Healthcare's higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than Xunlei.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xunlei	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

Summary

Xunlei and Definitive Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to TruBridge?

TruBridge (NASDAQ:TBRG) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

TruBridge has higher revenue and earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TruBridge	$346.84M	1.12	$4.21M	$0.20	129.25
Definitive Healthcare	$241.52M	0.38	-$138.93M	-$1.62	N/A

TruBridge has a net margin of 0.92% compared to Definitive Healthcare's net margin of -76.04%. TruBridge's return on equity of 18.75% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TruBridge	0.92%	18.75%	8.32%
Definitive Healthcare	-76.04%	4.04%	1.99%

In the previous week, Definitive Healthcare had 9 more articles in the media than TruBridge. MarketBeat recorded 17 mentions for Definitive Healthcare and 8 mentions for TruBridge. TruBridge's average media sentiment score of 0.75 beat Definitive Healthcare's score of 0.43 indicating that TruBridge is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TruBridge	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TruBridge has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

88.6% of TruBridge shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 10.7% of TruBridge shares are held by company insiders. Comparatively, 16.3% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

TruBridge currently has a consensus price target of $23.95, suggesting a potential downside of 7.35%. Definitive Healthcare has a consensus price target of $2.77, suggesting a potential upside of 218.74%. Given Definitive Healthcare's higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than TruBridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TruBridge	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

Summary

TruBridge beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to Bigcommerce?

Bigcommerce (NASDAQ:BIGC) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Bigcommerce has higher revenue and earnings than Definitive Healthcare. Bigcommerce is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bigcommerce	$334.94M	0.66	-$17.62M	-$0.22	N/A
Definitive Healthcare	$241.52M	0.38	-$138.93M	-$1.62	N/A

Bigcommerce has a net margin of 0.00% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Bigcommerce's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bigcommerce	N/A	N/A	N/A
Definitive Healthcare	-76.04%	4.04%	1.99%

In the previous week, Definitive Healthcare had 14 more articles in the media than Bigcommerce. MarketBeat recorded 17 mentions for Definitive Healthcare and 3 mentions for Bigcommerce. Definitive Healthcare's average media sentiment score of 0.43 beat Bigcommerce's score of 0.39 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bigcommerce	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Definitive Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Bigcommerce has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

79.2% of Bigcommerce shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 5.0% of Bigcommerce shares are held by company insiders. Comparatively, 16.3% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Bigcommerce currently has a consensus price target of $11.00, suggesting a potential upside of 297.11%. Definitive Healthcare has a consensus price target of $2.77, suggesting a potential upside of 218.74%. Given Bigcommerce's stronger consensus rating and higher probable upside, equities analysts plainly believe Bigcommerce is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bigcommerce	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

Summary

Definitive Healthcare beats Bigcommerce on 9 of the 16 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DH vs. The Competition

Export

Metric	Definitive Healthcare	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$90.96M	$16.38B	$39.44B	$12.46B
Dividend Yield	N/A	4.89%	3.20%	5.30%
P/E Ratio	-0.53	60.10	163.78	25.56
Price / Sales	0.38	26.80	622.72	72.25
Price / Cash	0.47	65.08	47.82	55.34
Price / Book	0.48	5.55	9.56	6.72
Net Income	-$138.93M	$379.18M	$1.03B	$333.62M
7 Day Performance	-5.86%	-4.12%	0.34%	0.35%
1 Month Performance	-14.06%	4.91%	9.50%	4.00%
1 Year Performance	-74.55%	-8.31%	164.60%	36.32%

Definitive Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DH Definitive Healthcare	3.4061 of 5 stars	$0.87 -2.1%	$2.77 +218.7%	-75.4%	$90.96M	$241.52M	N/A	970	Earnings Report
ECX ECARX	1.2332 of 5 stars	$1.11 -1.3%	N/A	-37.6%	$393.90M	$847.90M	N/A	1,432	Positive News
SPT Sprout Social	3.6987 of 5 stars	$6.50 -3.8%	$13.11 +101.9%	-74.1%	$387.44M	$457.55M	N/A	1,362	News Coverage Earnings Report Analyst Forecast
XNET Xunlei	1.4985 of 5 stars	$6.12 -1.8%	N/A	+35.0%	$384.74M	$460.43M	0.37	1,216	News Coverage Positive News
TBRG TruBridge	2.9107 of 5 stars	$25.75 0.0%	$23.95 -7.0%	+3.6%	$383.86M	$346.84M	128.73	3,500	Earnings Report Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DH) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Competitors

DH vs. ECX, SPT, XNET, TBRG, and BIGC

How does Definitive Healthcare compare to ECARX?

Summary

How does Definitive Healthcare compare to Sprout Social?

Summary

How does Definitive Healthcare compare to Xunlei?

Summary

How does Definitive Healthcare compare to TruBridge?

Summary

How does Definitive Healthcare compare to Bigcommerce?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Definitive Healthcare (DH) Competitors

DH vs. ECX, SPT, XNET, TBRG, and BIGC

How does Definitive Healthcare compare to ECARX?

Is DH or ECX more profitable?

Does the media refer more to DH or ECX?

Do insiders and institutionals hold more shares of DH or ECX?

Do analysts prefer DH or ECX?

Which has more risk and volatility, DH or ECX?

Which has higher valuation and earnings, DH or ECX?

Summary

How does Definitive Healthcare compare to Sprout Social?

Is SPT or DH more profitable?

Does the media favor SPT or DH?

Do insiders & institutionals hold more shares of SPT or DH?

Do analysts rate SPT or DH?

Which has more volatility and risk, SPT or DH?

Which has better valuation and earnings, SPT or DH?

Summary

How does Definitive Healthcare compare to Xunlei?

Which has better valuation and earnings, XNET or DH?

Is XNET or DH more profitable?

Does the media favor XNET or DH?

Which has more volatility and risk, XNET or DH?

Do insiders & institutionals hold more shares of XNET or DH?

Do analysts rate XNET or DH?

Summary

How does Definitive Healthcare compare to TruBridge?

Which has preferable valuation & earnings, TBRG or DH?

Is TBRG or DH more profitable?

Does the media refer more to TBRG or DH?

Which has more risk and volatility, TBRG or DH?

Do institutionals & insiders hold more shares of TBRG or DH?

Do analysts rate TBRG or DH?

Summary

How does Definitive Healthcare compare to Bigcommerce?

Which has preferable valuation & earnings, BIGC or DH?

Is BIGC or DH more profitable?

Does the media refer more to BIGC or DH?

Which has more risk and volatility, BIGC or DH?

Do institutionals & insiders hold more shares of BIGC or DH?

Do analysts rate BIGC or DH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools